Showing results (41-50 of 61) with videos related to
Sort By:
Pageof 7
Pediatric Pulmonology|April 1, 1994
Pulmonary vasculitis with hemorrhage in anaphylactoid purpuraW K Wright, H F Krous, W R Griswold, et al.Journal of the American Academy of Dermatology|January 10, 2001
Compliance with federal and state legislation by indoor tanning facilities in San DiegoC A Culley, J A Mayer, L Eckhardt, et al.European Journal of Human Genetics : EJHG|February 15, 2001
Linkage disequilibrium narrows locus for venous malformation with glomus cells (VMGLOM) to a single 1.48 Mbp YACA Irrthum, P Brouillard, O Enjolras, et al.Journal of Community Health|August 15, 2000
A national survey of sun safety activities at U.S. zoosM A Talosig, J A Mayer, L Eckhardt, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|May 26, 2018
Tinea capitis in children: a systematic review of managementA K Gupta, R R Mays, S G Versteeg, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|October 22, 2020
A position paper on the management of itch and pain in atopic dermatitis from the International Society of Atopic Dermatitis (ISAD)/Oriented Patient-Education Network in Dermatology (OPENED) task forceL Misery, A Belloni Fortina, M El Hachem, et al.The British Journal of Dermatology|March 17, 2020
Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients (≥ 6 to < 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open-label CADMUS Jr studyS Philipp, A Menter, A F Nikkels, et al.The British Journal of Dermatology|December 1, 2018
Use of an alternative method to evaluate erythema severity in a clinical trial: difference in vehicle response with evaluation of baseline and postdose photographs for effect of oxymetazoline cream 1·0% for persistent erythema of rosacea in a phase IV studyL F Eichenfield, J Q Del Rosso, J K L Tan, et al.The Journal of Dermatological Treatment|November 23, 2020
Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trialsK Reich, A M DeLozier, F P Nunes, et al.The British Journal of Dermatology|January 17, 2007
A systematic review of the safety of topical therapies for atopic dermatitisJ Callen, S Chamlin, L F Eichenfield, et al.Pageof 7